ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: TheraVasc

TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients

TheraVasc’s clinical trial of PAD drug shows safety in diabetic patients

September 19, 2011 4:18 pm by | 0 Comments

A phase 1 trial of a peripheral artery disease drug candidate from TheraVasc demonstrated safety in diabetic patients.The positive clinical trial data reported by Cleveland-based TheraVasc potentially puts the young ... Read more
Peripheral artery disease pill from TheraVasc heading to phase 2a trials

Peripheral artery disease pill from TheraVasc heading to phase 2a trials

July 5, 2011 11:15 am by | 0 Comments

TheraVasc plans to begin enrolling patients this month in a phase 2a clinical trial of its pill designed to treat peripheral artery disease.The clinical trial, which is expected to follow ... Read more
Peripheral artery disease drug developer TheraVasc raises $1.8M

Peripheral artery disease drug developer TheraVasc raises $1.8M

September 27, 2010 10:26 am by | 0 Comments

TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised a $1.8 million Series A1 round of investment capital. But the company isn't stopping there -- it's ... Read more
Max Endoscopy, TheraVasc get 250k investments from JumpStart

Max Endoscopy, TheraVasc get 250k investments from JumpStart

September 7, 2010 4:46 pm by | 0 Comments

Device maker MAX Endoscopy Inc. and drug developer TheraVasc Inc. each have received $250,000 follow-on investments from JumpStart Ventures, the investment arm of Northeast Ohio venture developer JumpStart Inc. The ... Read more
Theravasc Inc. wins $500,000 investment commitment to try vascular disease drug

Theravasc Inc. wins $500,000 investment commitment to try vascular disease drug

January 5, 2010 4:46 pm by | 0 Comments

Theravasc Inc., a Cleveland company that is reformulating an approved drug to treat vascular diseases, has received investment commitments of $500,000 to do its initial clinical study. ... Read more
Louisiana pharma startup TheraVasc moves, readies for clinical trials

Louisiana pharma startup TheraVasc moves, readies for clinical trials

June 17, 2009 12:50 pm by | 3 Comments

TheraVasc, based in Shreveport, Louisiana, wants to raise $2.5 million in a Series A round, said President Tony Giordano. It would close on most of the money by the fall ... Read more